Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma

Abstract

eExos+pPolymiR, which includes a pan-subtype anti-glioma-specific miR combination encoded in a polycistronic plasmid and a novel exosome delivery platform, represents a new and potentially powerful anti-GBM therapeutic.